Rao et al. 2020 (PRJNA665035)

General Details

Title Genes with 5′ terminal oligopyrimidine tracts preferentially escape global suppression of translation by the SARS-CoV-2 NSP1 protein
Organism
Number of Samples 15
Release Date 2020/09/22 00:00
Sequencing Types
Protocol Details

Study Links

Repository Details

SRA SRP284977
ENA SRP284977
GEO GSE158374
BioProject PRJNA665035

Publication

Title
Authors Rao S,Hoskins I,Tonn T,Garcia PD,Ozadam H,Cenik ES,Cenik C
Journal bioRxiv : the preprint server for biology
Publication Date 2021 May 25
Abstract Viruses rely on the host translation machinery to synthesize their own proteins. Consequently, they have evolved varied mechanisms to co-opt host translation for their survival. SARS-CoV-2 relies on a non-structural protein, Nsp1, for shutting down host translation. However, it is currently unknown how viral proteins and host factors critical for viral replication can escape a global shutdown of host translation. Here, using a novel FACS-based assay called MeTAFlow, we report a dose-dependent reduction in both nascent protein synthesis and mRNA abundance in cells expressing Nsp1. We perform RNA-Seq and matched ribosome profiling experiments to identify gene-specific changes both at the mRNA expression and translation level. We discover a functionally-coherent subset of human genes are preferentially translated in the context of Nsp1 expression. These genes include the translation machinery components, RNA binding proteins, and others important for viral pathogenicity. Importantly, we uncovered a remarkable enrichment of 5' terminal oligo-pyrimidine (TOP) tracts among preferentially translated genes. Using reporter assays, we validated that 5' UTRs from TOP transcripts can drive preferential expression in the presence of NSP1. Finally, we found that LARP1, a key effector protein in the mTOR pathway may contribute to preferential translation of TOP transcripts in response to Nsp1 expression. Collectively, our study suggests fine tuning of host gene expression and translation by Nsp1 despite its global repressive effect on host protein synthesis.
PMC PMC7523102
PMID 32995776
DOI
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)
SRR12693492 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693493 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693494 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693495 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693496 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693497 PRJNA665035 Homo sapiens HEK293 Ribo-Seq
SRR12693498 PRJNA665035 Homo sapiens HEK293 Ribo-Seq untreated
SRR12693499 PRJNA665035 Homo sapiens HEK293 Ribo-Seq untreated
SRR12693500 PRJNA665035 Homo sapiens HEK293 Ribo-Seq untreated
SRR14667085 PRJNA665035 Homo sapiens H1299 Ribo-Seq
SRR14667086 PRJNA665035 Homo sapiens H1299 Ribo-Seq
SRR14667087 PRJNA665035 Homo sapiens H1299 Ribo-Seq
SRR14667088 PRJNA665035 Homo sapiens H1299 Ribo-Seq
SRR14667089 PRJNA665035 Homo sapiens H1299 Ribo-Seq
SRR14667090 PRJNA665035 Homo sapiens H1299 Ribo-Seq
Run Accession Study Accession Scientific Name Cell Line Library Type Treatment GWIPS-viz Trips-Viz Reads BAM BigWig (F) BigWig (R)

ⓘ For more Information on the columns shown here see: About